Loading
Latest filing published 16 Dec 2025 for Traws Pharma, Inc..
No signal scores available.
Charles David Pauza discloses dealings in Traws Pharma, Inc. to SEC (Form 4). Between 1 April 2024 and 12 December 2025, the trades on record add up to 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 16 December 2025 with a share grant in Traws Pharma, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations